International survey of chronic total occlusion percutaneous coronary intervention operators.

Autor: Simsek B; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Rempakos A; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Kostantinis S; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Alexandrou M; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Karacsonyi J; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Rangan BV; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Mastrodemos OC; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Mutlu D; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Abi Rafeh N; Department of Cardiology, North Oaks Health System, Hammond, Louisiana, USA., Alaswad K; Division of Cardiology, Henry Ford Hospital, Detroit, Michigan, USA., Avran A; Centre Hospitalier de Valenciennes, Valenciennes, France., Azzalini L; Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA., ElGuindy A; Adult Cardiology Department, Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt., Egred M; Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, UK., Goktekin O; Department of Cardiology, Memorial Bahcelievler Hospital, Istanbul, Turkey., Gorgulu S; Department of Cardiology, Biruni University, Istanbul, Turkey., Jaber W; Department of Cardiology, Emory University, Atlanta, Georgia, USA., Kearney KE; Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA., Kirtane AJ; Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York, USA., Lombardi WL; Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA., Mashayekhi K; Department for Internal Medicine and Cardiology, Heartcenter Lahr, Lahr, Germany., McEntegart M; Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York, USA., Nicholson W; Department of Cardiology, Emory University, Atlanta, Georgia, USA., Rinfret S; Department of Cardiology, Emory University, Atlanta, Georgia, USA., Allana SS; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Sandoval Y; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Nicholas Burke M; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA., Brilakis ES; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
Jazyk: angličtina
Zdroj: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2024 Jan; Vol. 103 (1), pp. 12-19. Date of Electronic Publication: 2023 Nov 20.
DOI: 10.1002/ccd.30914
Abstrakt: Background: Contemporary chronic total occlusion (CTO) percutaneous coronary intervention (PCI) practice has received limited study.
Aim: To examine the contemporary CTO PCI practice.
Methods: We performed an online, anonymous, international survey of CTO PCI operators.
Results: Five hundred forty-five CTO PCI operators and 190 interventional cardiology fellows with an interest in CTO PCI participated in this survey. Almost half were from the United States (41%), most (93%) were men, and the median h/week spent in the hospital was 58. Median annual case numbers were 205 (150-328) for PCIs and 20 (5-50) for CTO PCIs. Almost one-fifth (17%) entered CTO cases into registries, such as PROGRESS-CTO (55%) and EuroCTO (20%). More than one-third worked at academic institutions (39%), 31% trained dedicated CTO fellows, and 22% proctored CTO PCI. One-third (34%) had dedicated CTO PCI days. Most (51%) never discharged CTO patients the same day, while 17% discharged CTO patients the same day >50% of the time. After successful guidewire crossing, 38% used intravascular imaging >90% of the time. Most used CTO scores including J-CTO (81%), PROGRESS-CTO (35%), and PROGRESS-CTO complications scores (30%). Coronary artery perforation was encountered within the last month by 19%. On a scale of 0-10, the median comfort levels in treating coronary artery perforation were: covered stents 8.8 (7.0-10), coil embolization 5.0 (2.1-8.5), and fat embolization 3.7 (0.6-7.3). Most (51%) participants had a complication cart/kit and 25% conducted regular complication drills with catheterization laboratory staff.
Conclusion: Contemporary CTO PCI practices vary widely. Further research on barriers to following the guiding principles of CTO PCI may improve patient outcomes.
(© 2023 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: